Archive · 21 Nov 2025
Weight Loss Drugs in India: Misconceptions and Correct Usage
Weight loss drugs like Rybelsus, Wegovy, Ozempic, and Mounjaro are popular in India, but people often don't understand how to use them correctly.
They think these drugs will make them lose a lot of weight quickly and that they can stop taking them once they've lost the weight.
This is not true.
These drugs have side effects and should only be used with a doctor's help.
To get the best results, people should also change their diet and exercise habits.
GLP-1 RAs (Rybelsus, Wegovy, Ozempic, Mounjaro) are widely discussed for weight loss in India
Public understanding of these drugs is often incomplete or incorrect
Common misconceptions include expecting large weight loss, short-term use, and suitability for mild overweight
GLP-1 RAs have serious side effects and should be used under medical supervision
Correct usage involves lifestyle changes and regular medical follow-ups
- Who
- People in India using or considering weight loss drugs like Rybelsus, Wegovy, Ozempic, and Mounjaro
- What
- Misusing or misunderstanding these drugs' effects and proper usage
- When
- Currently, as these drugs have gained popularity in India
- Where
- India, particularly in gyms, beauty salons, offices, and social media platforms
- Why
- To lose weight quickly and easily, often without understanding the drugs' true effects and necessary lifestyle changes
Casual Users
Medical Professionals
Weight Loss Expectations
Casual Users
Expect large, quick weight loss with short-term drug use
Medical Professionals
Actual weight loss varies; drugs should be used long-term with lifestyle changes
Suitability for Mild Overweight
Casual Users
Believe drugs are suitable for cosmetic weight loss
Medical Professionals
Drugs should be used for medically significant obesity, not cosmetic purposes
Side Effects Awareness
Casual Users
Trivialize or ignore side effects
Medical Professionals
Acknowledge and monitor side effects, emphasizing the need for medical supervision
- Drug Names
- Rybelsus, Wegovy, Ozempic, Mounjaro (generic: semaglutide, tirzepatide)
- Common Misconception
- All users will lose 20-25 kg
- Actual Weight Loss
- Variable, ranging from 2-5 kg to 20 kg, with 5% showing minimal/no change
- Cost per Month
- Rs 10,000 - Rs 25,000 (lower prices available)
- Recommended BMI for Use
- 30 kg/m² or above, or 27 kg/m² with associated conditions
- Side Effects
- Nausea, vomiting, diarrhea, constipation, acid reflux, muscle loss, intestinal paralysis, 'Ozempic face'